BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199
Authors: Kamil Bojarczuk*, Binu K Sasi*, Stefania Gobessi, Idanna Innocenti, Gabriele Pozzato, Luca Laurenti, and Dimitar G Efremov * - równorzędni współautorzy
Published in: Blood
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine
SJR best quartile: Q1